Unlock instant, AI-driven research and patent intelligence for your innovation.

Preparation method of (1R,3S)-3-aminocyclopentanol chiral acid salt

A technology of aminocyclopentanol and chiral acid, which is applied in the direction of carboxylate preparation, carboxylate preparation, sulfonate preparation, etc., can solve the problem of no separation of isomers, no chiral control of the synthesis method, and optical purity and low total yield, to achieve the effects of low production cost, easy large-scale production, easy separation and purification

Active Publication Date: 2020-04-17
SHANGHAI DESANO CHEM PHARMA +3
View PDF5 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0011] Chinese patent CN201210090148.X discloses a method for synthesizing cis-3-amino-cyclopentanol hydrochloride using hydroxylamine hydrochloride and benzyloxycarbonyl chloride as starting materials, although the cis-3-amino-cyclopentanol hydrochloride of the patent The purity GC content of the hydrochloride reaches 98%, and the total yield reaches 36.5%, but its synthesis method has no chiral control, and the obtained product is (1R,3S)-3-aminocyclopentanol and ( The cis mixture of 1S,3S)-3-aminocyclopentanol, without resolution of isomers, if calculated according to the single optical purity of (1R,3S)-3-aminocyclopentanol hydrochloride after resolution In terms of purity and total yield, the optical purity and total yield are lower

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Preparation method of (1R,3S)-3-aminocyclopentanol chiral acid salt
  • Preparation method of (1R,3S)-3-aminocyclopentanol chiral acid salt
  • Preparation method of (1R,3S)-3-aminocyclopentanol chiral acid salt

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0037] When R 1 Be ethyl, when R is phenyl, the preparation of formula V compound:

[0038]

[0039] Dissolve 100g of formula VI compound (R-mandelic acid) in 350ml of ethanol, add 28.4g of concentrated sulfuric acid at room temperature, then reflux for 5 hours to complete the reaction, cool to room temperature, and the resulting esterification solution (containing formula V compound) is directly used in Next reaction.

Embodiment 2

[0041] The preparation of formula IV compound:

[0042]

[0043] Add 91.4g of hydroxylamine hydrochloride to 550ml of methanol to obtain solution 1, and use it for later use; add 120g of potassium hydroxide to 300ml of ethanol to obtain solution 2 for later use; below 10°C, mix solution 1 and solution 2, and add dropwise The esterification solution (containing the compound of formula V) prepared in Example 1, after the dropwise addition, was reacted at 15-25° C. for 2 hours, and the reaction was terminated. The pH of the reaction solution was adjusted to 7.0-7.5, concentrated, and the concentrate was treated with acetic acid Ethyl ester was recrystallized at room temperature to obtain the compound of formula IV (89 g, molar yield 81%).

Embodiment 3

[0045] The preparation of formula III compound:

[0046]

[0047]The sodium periodate of 129g is dissolved in the mixed solvent of the water of 300ml and the methanol of 600ml, the cyclopentadiene of 79.4g is added, stir well, the methanol solution of compound of formula IV is added dropwise (100g compound of formula IV is dissolved in 400ml of Methanol), after the dropwise addition, react at 15-25°C for 15-18 hours, finish the reaction, filter, concentrate, add a mixed solvent of 50ml of methanol and 500ml of water to the concentrated mother liquor, stir, filter, and Add 100ml of dichloromethane to the cake, reflux and stir for 1 hour, then dropwise add 600ml of tertiary methyl ether solution, crystallize, collect the precipitated crystals, and dry to obtain the compound of formula III (118.7g, molar yield 86.1%, isomeric body is less than 0.50%).

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a preparation method of a (1R,3S)-3-aminocyclopentanol chiral acid salt, wherein the (1R, 3S)-3-aminocyclopentanol chiral acid salt is a compound represented by a formula I, the preparation method comprises the step e or steps d-e or steps c-d-e or steps b-c-d-e or steps a-b-c-d-e in the following synthetic route, and R1 is C1-C4 alkyl, and R is any one of phenyl, substituted phenyl and benzyl. According to the method, an easily available compound (namely R-mandelic acid) represented by a formula VI is used as a raw material; the finally prepared (1R, 3S)-3-aminocyclopentanol chiral acid salt can reach the enantiomeric purity of 99.9%, is high in optical purity and easy to achieve the industrial production of the single-configuration (1R, 3S)-3-aminocyclopentanol chiral acid salt, and has significant progress compared with the prior art.

Description

technical field [0001] The invention relates to a preparation method of (1R,3S)-3-aminocyclopentanol chiral acid salt, which belongs to the technical field of medicinal chemistry. Background technique [0002] Bictegravir is an innovative once-daily integrase strand transfer inhibitor (INSTI) currently in Phase 3 clinical trials as part of a single-tablet regimen in combination with FTC / TAF for the treatment of HIV infection. GileadSciences announced data from a Phase 2 clinical study evaluating the efficacy, safety and tolerability of the combination of bictegravir (BIC, 75mg) and emtricitabine / tenofovir (200mg / 25mg, FTC / TAF) against HIV-1 infection newly diagnosed adult patients. At the same time, the comparison is the combination of dolutegravir (50mg) (DTG) and emtricitabine / tenofovir alafenamide (200mg / 25mg) (FTC / TAF). The results of the study found that both regimens showed high virological response rates at weeks 24 and 48. The specific chemical structural formula ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07C215/44C07C213/02C07C59/255C07C51/41C07C309/19C07C303/32C07C59/245C07C69/732C07C67/08C07C259/06C07D261/20C07C235/36C07C231/12
CPCC07C213/02C07C51/412C07C303/32C07C67/08C07C259/06C07D261/20C07C231/12C07B2200/07C07C2601/08C07C2602/42C07C69/732C07C235/36C07C215/44C07C59/255C07C59/245C07C309/19Y02P20/55
Inventor 李金亮赵楠靳家玉华嗣恺董志伟俞得宝
Owner SHANGHAI DESANO CHEM PHARMA